Literature DB >> 1000469

Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer.

P H Sugarbaker, N Zamcheck, F D Moore.   

Abstract

Monthly serial postoperative CEA determinations, three-monthly system review plus physical examination, and a battery of six-monthly laboratory and radiologic tests were compared in order to evaluate each in detection of recurrent colorectal cancer. Twelve of the 33 patients studied prospectively developed recurrent disease. In this study CEA was found not to be a substitute for careful clinical follow-up, but if used in a serial manner it was a useful adjunct for detection of early recurrent cancer, especially intra-hepatic and retroperitoneal disease recurring in patients with elevated pretreatment CEA levels. The other laboratory and radiologic tests employed were often useful to confirm progressing disease, but they did not reveal any first evidence of recurrent disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000469     DOI: 10.1002/1097-0142(197612)38:6<2310::aid-cncr2820380618>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.

Authors:  C J Fabian; R Molina; M Slavik; S Dahlberg; S Giri; R Stephens
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

2.  Symposium: The management of recurrent colorectal cancer.

Authors:  F F Attiyeh; H Ellis; M Killingback; G D Oates; P F Schofield; H J Staab; G Steele; P H Sugarbaker
Journal:  Int J Colorectal Dis       Date:  1986-07       Impact factor: 2.571

3.  Routine compared with nonscheduled follow-up of patients with "curative" surgery for colorectal cancer.

Authors:  R Bergamaschi; J P Arnaud
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

4.  The usefulness and limitations of CEA assay in the management of colorectal cancer.

Authors:  H Tomoda; M Furusawa
Journal:  Jpn J Surg       Date:  1981-01

5.  Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow up of patients with colorectal cancer.

Authors:  W F Miles; J D Greig; J Seth; C Sturgeon; S J Nixon
Journal:  Br J Gen Pract       Date:  1995-06       Impact factor: 5.386

6.  Carcinoembryonic antigen: physician attitudes, patterns of use, and impact upon patient care.

Authors:  S L Vest; J K Roche
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

7.  Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.

Authors:  J H Wanebo; M Stearns; M K Schwartz
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

8.  Serial determinations of carcinoembryonic antigen for early detection of recurrent gastric cancer.

Authors:  R Tamada; Y Hiramoto; Y Abe; T Nouzuka; T Okamura; H Masuda; T Kano; R Kumashiro; K Inokuchi
Journal:  Jpn J Surg       Date:  1982

Review 9.  Carcinoembryonic antigen in patients with breast or colon cancer.

Authors:  Y N Lee
Journal:  West J Med       Date:  1978-11

10.  Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.

Authors:  K A Chester; R H Begent
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.